Hong Kong Stock Movement | CARsgen Therapeutics-B (02171.HK) rises over 9% against the market; Kailimei becomes the first solid tumor CAR-T product in the commercial insurance innovative drug catalog

date
17/11/2026
Zhitong Finance APP has learned that CARsgen Therapeutics-B (02171.HK) rose more than 9% against the market trend. As of press time, it was up 7.08% at HK$10.74, with a turnover of HK$19.8707 million.